CAI
GILD icon

Capital Advisors Inc’s Gilead Sciences GILD Stock Holding History

Capital Advisors Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$456K Sell
3,611
-190
-5% -$25K 0.01% 247
2026
Q1 		$530K Buy
3,801
+560
+17% +$78.4K 0.01% 219
2025
Q4 		$398K Buy
3,241
+739
+30% +$89.8K 0.01% 234
2025
Q3 		$278K Buy
2,502
+244
+11% +$27.7K ﹤0.01% 269
2025
Q2 		$250K Buy
2,258
+179
+9% +$19.1K ﹤0.01% 282
2025
Q1 		$233K Buy
+2,079
New +$215K ﹤0.01% 286
2018
Q3 		– Sell
-108,334
Closed -$7.67M – 185
2018
Q2 		$7.67M Buy
108,334
+3,469
+3% +$245K 0.46% 70
2018
Q1 		$7.91M Sell
104,865
-78,029
-43% -$6.2M 0.47% 69
2017
Q4 		$13.1M Sell
182,894
-7,730
-4% -$587K 0.77% 38
2017
Q3 		$15.4M Sell
190,624
-4,041
-2% -$309K 0.95% 24
2017
Q2 		$13.8M Sell
194,665
-2,238
-1% -$149K 0.86% 30
2017
Q1 		$13.4M Buy
196,903
+17,534
+10% +$1.23M 0.87% 34
2016
Q4 		$12.8M Buy
179,369
+99,961
+126% +$7.43M 0.89% 25
2016
Q3 		$6.28M Buy
79,408
+4,829
+6% +$392K 0.94% 51
2016
Q2 		$6.22M Buy
74,579
+8,490
+13% +$753K 0.96% 52
2016
Q1 		$6.07M Buy
66,089
+62,264
+1,628% +$5.61M 0.99% 50
2015
Q4 		$387K Sell
3,825
-44
-1% -$4.58K 0.07% 94
2015
Q3 		$380K Buy
3,869
+114
+3% +$12.7K 0.07% 94
2015
Q2 		$440K Sell
3,755
-48,565
-93% -$5.31M 0.08% 87
2015
Q1 		$5.13M Sell
52,320
-3,045
-5% -$309K 0.63% 57
2014
Q4 		$5.22M Buy
55,365
+1,348
+2% +$139K 0.97% 51
2014
Q3 		$5.75M Sell
54,017
-46,163
-46% -$4.52M 1.18% 51
2014
Q2 		$8.31M Buy
+100,180
New +$7.8M 1.61% 16

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Advisors Inc's GILD Position: Q2 2026 in Review

Capital Advisors Inc reduced its Gilead Sciences (GILD) stake by 5% in Q2 2026, selling an estimated $25K and leaving 3,611 shares worth $456K. The position accounts for 0.01% of the portfolio, ranked #247.

Capital Advisors Inc first reported a position in GILD in Q2 2014 and has held it in 23 quarters since. The position peaked at $15.4M in Q3 2017. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Capital Advisors Inc held 3,611 shares of Gilead Sciences worth $456K as of Q2 2026.
  • Capital Advisors Inc sold 190 Gilead Sciences shares in Q2 2026, an estimated $25K.
  • Gilead Sciences made up 0.01% of Capital Advisors Inc's portfolio in Q2 2026, its #247 holding.
  • Capital Advisors Inc first reported a position in Gilead Sciences in Q2 2014 and has held it in 23 quarters since.
  • Capital Advisors Inc's Gilead Sciences position peaked at $15.4M in Q3 2017.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.